Sign in to view content

TIE2, VEGF, and Integrin Receptor Interplay and its Role in Retinal Disease

Peter K. Kaiser, MD FASRS

Video
Published 2020

Related

Pooled Safety Analysis and Immunogenicity of a Single Intravitreal Injection of JNJ-1887 (Gene Therapy, AAVCAGsCD59) in Patients With AMD
Christine Kay, MD
Annual Meeting Talks
2024
Endophthalmitis After Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Inhibitors: Management and Visual Outcomes
Kunyong Xu, MD, MHSc
Annual Meeting Talks
2018
Predictors of Post-injection Endophthalmitis: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength
Tarek S. Hassan, MD, FASRS
Updates from the Field
2019

Category: AMD-Neovascular

See more